We quantified and compared plasma levels of cytokines and chemokines including IL-4, IL-5, IL-6, IP-10, VEGF-A, and IFNγ at baseline, at the time of follow up and between baseline and follow-up between individuals that had KS recurrence versus those who had sustained remission. This evidence concerns the gene CXCL10 and Kaposi's sarcoma.